Zydus Life rises on in-principle approval from WHO for typhoid vaccine
Zydus Lifesciences advanced 1.71% to Rs 1,005.05 after the company received in principle acceptability from World Health Organisation (WHO) for its ZyVac TCV vaccine.
Stock market update: Nifty Pharma index falls 1.56%
The Nifty Pharma index closed on a negative note on Wednesday. Shares of Granules India Ltd.(up 1.8 per cent), Zydus ...
Stock market update: Nifty Pharma index 1.56%
The Nifty Pharma index closed on a note on Wednesday. Shares of Granules India Ltd.(up 1.8 per cent), Zydus Lifesciences Ltd.
Closing Bell: Sensex ends volatile trade 139 pts lower, Nifty below 24,450; M&M, Sun Pharma drop 3% each
After a brief dip at the opening, domestic equity indices Sensex and Nifty50 rallied on Wednesday, despite ongoing foreign ...